Characterized parts

Find below some of our most important and best-characterized parts.

Measurement Kit

Main Article: Measurement

[http://partsregistry.org/wiki/index.php?title=Part:BBa_K203100 Part:BBa_K203100]

Fig. 1: Plasmid map of pSMB_MEASURE. BBB sites are shown in red, core promoter in light blue and proximal promoter in dark blue.

We separated JeT's core promoter from its proximal promoter by a HindIII site; it can therefore be used for for the de novo creation of promoters containing the JeT core promoter or for modifying the strength of a promoter by core promoter swapping.

In addition, it contains a FRT site which will allow for stable integration into mammalian cells also containing a FRT site. Thus, it provides the possibility to characterize the promoter in a defined genome and in this way helps to avoid some of the challenges we identified for promoter characterization in mammalian systems. For the same reason, it also contains a mammalian selection marker (hygromycin). For the generation of the plasmid, please see [http://partsregistry.org/Part:BBa_K203100:Design part design]. As a reporter gene, it contains GFP, which is followed by a SV40 mammalian terminator. We generated another plasmid pSMB_REFERENCE, which contains mCherry instead of GFP. It can be used for normalizations to transfection efficiency in Flow Cytometry and image analysis.

Core promoters

Fig. 2: JeT strength changes depending on conditions We characterize GFP expression from [http://partsregistry.org/wiki/index.php?title=Part:BBa_K203112 JeT] and [http://partsregistry.org/Part:BBa_I712004 CMV] fluctuate dependent on condition (Everolimus induces extreme starvation). Measured by Flow cytometry 20 hours after transfection (unless specified otherwise).

Main Article: Core promoters

[http://partsregistry.org/wiki/index.php?title=Part:BBa_K203113 Part:BBa_K203113]

We cloned the CMV core promoter from [http://partsregistry.org/Part:BBa_I712004 Part:BBa_I712004] in front of the JeT proximal promoter from part [http://partsregistry.org/wiki/index.php?title=Part:BBa_K203112 Part:BBa_K203112] to obtain JeT_CMV. This construct can be used to create novel promoters containing the CMV core promoter. We characterized this construct in three different cell lines, HeLa, MCF-7 and U2-OS and found it to have 50%-60% percent of JeT's activtiy depending on the cell line (Fig. 3). Thereby, the HeLa cell line was measured five times and the MCF-7 and U2-OS cell line measurements were performed four times. The fact that variations in the core promoter can be used to vary expression strength of a certain promoter of interest comes in useful if the transfer function of an existing promoter is to be altered. It can also be used to further diversify the synthetic promoters we created.

Promoters created by RA-PCR

Main article: Synthetic promoters

All synthetic promoters contain the core promoter of [http://partsregistry.org/wiki/index.php?title=Part:BBa_K203112 Part:BBa_K203112] and were screened / measured in [http://partsregistry.org/wiki/index.php?title=Part:BBa_K203100 Part:BBa_K203100].

[http://partsregistry.org/wiki/index.php?title=Part:BBa_K203110 BBa_K203110], [http://partsregistry.org/wiki/index.php?title=Part:BBa_K203118 BBa_K203118], [http://partsregistry.org/wiki/index.php?title=Part:BBa_K203111 BBa_K203111], [http://partsregistry.org/wiki/index.php?title=Part:BBa_K203109 BBa_K203109] and others

As a first application of RA-PCR, we have created a library of constitutive promoters. We performed RA-PCR on oligos containing binding sites for some well known generally activating transcription factors (Sp1, Ap1,CREB, NF-Y) which we identified from literature search [2],[3]]. We also added NF-κB responsive oligos as NF-κB has non-specific activity and is therefore used by a variety of viral constitutive promoters, e.g. the HIV promoter [4]. We picked 24 colonies, two of which we dismissed after a test digest (not shown). Fig. 5 shows the sequence analysis of some randomly selected clones and demonstrates that RA-PCR is able to generate randomized repeats of oligos. We then measured the activity of the clones we picked by applying the Concept of Relative Expression Units (REU) we developed. Fig. 4 shows that we have been able to create a library of promoters of varying strength, some of which have an expression strength higher than JeT (which was not accomplished by JeT's developers, although attempted [1]). Such a library is of great value for fine-tuning gene expression levels. Selected clones were characterized by an independent method (image analysis) and submitted to the registry.

Fig. 3: Flow cytometry measurement data of JeT_CMV (REU) in different cell lines. The three cell lines MCF-7, U2-OS and HeLa were cotransfected with the JeT_CMV promoter coupled to GFP and a reference plasmid including the promoter JeT coupled to mCherry. The relative fluorescence (REU) of GFP was measured 20 hours after transfection. The MCF-7 and the U2-OS cell line were measured four times and the HeLa cell line five times. The standard error of the mean (SEM) is indicated by the error bars.

Fig. 4: A library of constitutive promoters created by RA-PCR Promoters were analyzed by the standards developed in the Measurement part of our project in HeLa cells.

Fig. 5: RA-PCR generates randomized repeats of transcription factor binding sites. Sequence analysis of clones of constitutive promoters generated by RA-PCR. Transcription factor binding sites are marked in color, random sequences in light grey. Annealing sequences are shown in bold and bold italic.

[http://partsregistry.org/wiki/index.php?title=Part:BBa_K203119 BBa_K203119]

We characterized clone 31 of our library of NF-κB responsive promoters by flow cytometry (3 independent experiments, each experiment having 3 replicates) and found it to be upregulated by approx. 100% (Fig. 6) in response to TNF-α. We also did a timecourse measurement of induction (Fig. 7). To verify our assumption that promoters created by RA-PCR are specific to the pathway of interest, we tried to induce clone 31 by a wide variety of conditions (full medium, full medium lacking growth factors / serum, minimal medium / starvation and pPARγ induction by Thiazolidinedione) and found no change in indcution levels (Fig. 8). Also, we show that the promoter is active only if p65, a component of NF-κB, localizes to the nucleus (Fig. 9).

Fig. 6: BBa_K203119 is a promoter induced approximately by 100% by TNF-α. REU was determined by flow cytometry, 3 experiments each with 3 replicates	Fig. 7: Timecourse of induction. Measured by image analysis. See discussion for explanation of the deviation between the two methods.
Fig. 8: BBa_K203119 responds only to TNF-α and is not induced by other conditions. U2-OS Cells transfected with BBa_K203119 in BBa_K203100 were subjected to a variety of conditions (full medium DMEM+++, full medium lacking growth factors / serum DMEM++, starvation by minimal medium and pPARγ induction by Thiazolidinedione) and did not show any significant induction or repression.	Fig. 9: BBa_K203119 is only active if NF-κB is localized to the nucleus. Cells were cotransfected with BBa_K203119 in [http://partsregistry.org/Part:BBa_K203100 BBa_K203100] and a p65-mCherry-fusion protein (kind gift of N. Brady, BioQuant). Only if the red fluorescence is localized to the nucleus, bright green fluorescence can be observed.

Targeting Signals

Main article: Outlook and Summary

Protein domains for targeting to sub-cellular compartments. We intend to use this to visualize multiple pathways. All parts below were characterized in devices consisting of [http://partsregistry.org/Part:BBa_I712004 BBa_I712004 (CMV)], the targeting signal, [http://partsregistry.org/wiki/index.php?title=Part:BBa_K203103 BBa_K203103 (GFP)] and [http://partsregistry.org/wiki/index.php?title=Part:BBa_K203102 BBa_K203102 (PolyA signal/terminator)].

[http://partsregistry.org/wiki/index.php?title=Part:BBa_K203000 BBa_K203000]

Shown to localize proteins to the plasma membrane.

[http://partsregistry.org/Part:BBa_K203101 BBa_K203101]

Shown to localize proteins to the ER membrane. An expression device consisting of Part:BBa_I712004 (CMV) Part:BBa_K203103 (GFP), Part:BBa_K203101 (Sar-1) and Part:BBa_K203102 (terminator) was assembled for this characterization.

References

[1] Tornoe J. Generation of a synthetic mammalian promoter library by modification of sequences spacing transcription factor binding sites. Gene 297: 21-32 (2002).

[2] Edelman G. M., Meech R., Owens G. C. & Jones F. S. Synthetic promoter elements obtained by nucleotide sequence variation and selection for activity. PNAS 97: 3038-43 (2000).

[3] Ogawa R. Construction of strong mammalian promoters by random cis-acting element elongation. Biotechniques 42: 628-632 (2007).

[4] Rattner A. NF-κB activates the HIV promoter in neurons. EMBO 12: 4261–4267 (1993).